SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.68-2.4%Dec 12 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (1923)11/2/2000 5:23:41 PM
From: Biomaven  Read Replies (1) of 52153
 
Rick,

For chronic B cell depletion

Those reports sound like it's a one-time deal - they seem to be claiming that they destroy the current crop of B cells, and the replacements don't cause a problem.

The recent reports of Rituxan in RA are also very interesting:

Message 14687597

Quite a day out there today. I was hurt by the continuing SEPR weakness and IGEN meltdown, but the rest of my stocks did great.

Finally seeing a little post-tax-loss buying as well.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News